Using disease- modifying treatments in MS - new guidance - Association of British Neurologists

This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.

News & Press: ABN News

Email to a Friend

Using disease- modifying treatments in MS - new guidance

07 May 2025 (0 Comments)
Posted by: Katie Hall

Share |

Available via the BMJ website.

This updated guidance provides a consensus- based approach to using DMTs. We provide recommendations for eligibility, starting, monitoring, switching and stopping of DMTs; pregnancy; equitable access to DMT; autologous haemopoietic stem- cell transplantation; and use of generics. We highlight best practice where it exists and discuss future priorities.